Literature DB >> 20096773

A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.

Petra C F Oyston1, Gabriela Mellado-Sanchez, Marcela F Pasetti, James P Nataro, Richard W Titball, Helen S Atkins.   

Abstract

There is a need to develop effective countermeasures for Yersinia pestis, the etiologic agent of plague and a potential bioterrorism agent. Salmonella and Shigella spp. deleted in the guaBA genes involved in guanine biosynthesis have been shown to be attenuated in vivo. In this study, we sought to determine whether deletion of the guaBA operon would render Y. pestis auxotrophic for guanine and avirulent; such a strain could serve as a live attenuated plague vaccine candidate. A Y. pestis guaBA mutant was generated by specific deletion of a segment of the guaBA operon, producing a guanine auxotroph that was highly attenuated in a mouse model of Y. pestis infection. Furthermore, mice vaccinated with a single dose of 7x10(4)CFU via the intravenous route were fully protected against subsequent lethal challenge with the Y. pestis parental strain. These findings identify guaBA as a target for deletion to generate a live attenuated plague vaccine. Crown Copyright 2010. Published by Elsevier India Pvt Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096773      PMCID: PMC2857377          DOI: 10.1016/j.micpath.2010.01.005

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  31 in total

1.  Temporal global changes in gene expression during temperature transition in Yersinia pestis.

Authors:  Vladimir L Motin; Anca M Georgescu; Joseph P Fitch; Pauline P Gu; David O Nelson; Shalini L Mabery; Janine B Garnham; Bahrad A Sokhansanj; Linda L Ott; Matthew A Coleman; Jeffrey M Elliott; Laura M Kegelmeyer; Andrew J Wyrobek; Thomas R Slezak; Robert R Brubaker; Emilio Garcia
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

2.  High efficiency transformation of E. coli by high voltage electroporation.

Authors:  W J Dower; J F Miller; C W Ragsdale
Journal:  Nucleic Acids Res       Date:  1988-07-11       Impact factor: 16.971

Review 3.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  T V Inglesby; D T Dennis; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; J F Koerner; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; M Schoch-Spana; K Tonat
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

Review 4.  Plague immunization. I. Past and present trends.

Authors:  K F Meyer; D C Cavanaugh; P J Bartelloni; J D Marshall
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

5.  Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants.

Authors:  S C Straley; P A Harmon
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

7.  Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.

Authors:  Karen L Kotloff; Marcela F Pasetti; Eileen M Barry; James P Nataro; Steven S Wasserman; Marcelo B Sztein; William D Picking; Myron M Levine
Journal:  J Infect Dis       Date:  2004-10-19       Impact factor: 5.226

8.  Effectiveness of live or killed plague vaccines in man.

Authors:  K F Meyer
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates.

Authors:  Yehuda Flashner; Emanuelle Mamroud; Avital Tidhar; Raphael Ber; Moshe Aftalion; David Gur; Shirley Lazar; Anat Zvi; Tamar Bino; Naomi Ariel; Baruch Velan; Avigdor Shafferman; Sara Cohen
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.

Authors:  Araceli E Santiago; Leah E Cole; Augusto Franco; Stefanie N Vogel; Myron M Levine; Eileen M Barry
Journal:  Vaccine       Date:  2009-03-03       Impact factor: 3.641

View more
  7 in total

Review 1.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

2.  Helicobacter pylori relies primarily on the purine salvage pathway for purine nucleotide biosynthesis.

Authors:  George Liechti; Joanna B Goldberg
Journal:  J Bacteriol       Date:  2011-12-22       Impact factor: 3.490

3.  Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.

Authors:  Estela M Galván; Manoj Kumar Mohan Nair; Huaiqing Chen; Fabio Del Piero; Dieter M Schifferli
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

4.  Binding affects the tertiary and quaternary structures of the Shigella translocator protein IpaB and its chaperone IpgC.

Authors:  Philip R Adam; Mrinalini K Patil; Nicholas E Dickenson; Shyamal Choudhari; Michael Barta; Brian V Geisbrecht; Wendy L Picking; William D Picking
Journal:  Biochemistry       Date:  2012-05-01       Impact factor: 3.162

Review 5.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 6.  Plague: Infections of Companion Animals and Opportunities for Intervention.

Authors:  Petra C F Oyston; Diane Williamson
Journal:  Animals (Basel)       Date:  2011-06-21       Impact factor: 2.752

7.  Selective Protective Potency of Yersinia pestis ΔnlpD Mutants.

Authors:  S V Dentovskaya; S A Ivanov; P Kh Kopylov; R Z Shaikhutdinova; M E Platonov; T I Kombarova; T V Gapel'chenkova; S V Balakhonov; A P Anisimov
Journal:  Acta Naturae       Date:  2015 Jan-Mar       Impact factor: 1.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.